TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

May 31, 2000

Conditions
Tuberculosis
Interventions
OTHER

Nucleic Acid Amplification Methods for diagnosis

no intervention

Trial Locations (14)

10037

Harlem Hospital Center, New York

30303

Emory University School of Medicine, Atlanta

60611

Chicago-Lakeside VAMC, Chicago

72205

Central Arkansas Veterans Health System, Little Rock

78284

Audi L. Murphy VA Hospital, San Antonio

80204

Denver Department of Public Health and Hospitals, Denver

90033

LA County/USC Medical Center, Los Angeles

94110

University of California, San Francisco, San Francisco

98104

Seattle King County Health Department, Seattle

76107-2699

University of North Texas Health Science Center, Fort Worth

Canada V5Z 4R4

University of British Columbia, Vancouver

CANADA R3A 1R8

University of Manitoba, Winnipeg

Unknown

Nelson R. Mandela School of Medicine, Durban

Makerere University Medical School, Kampala

All Listed Sponsors
collaborator

US Department of Veterans Affairs

FED

lead

Centers for Disease Control and Prevention

FED

NCT00023439 - TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment | Biotech Hunter | Biotech Hunter